EFDID: 560313EFD: View Filing

Issuer: Vesalius Longevity Labs (Canada) Inc. (0002074113) - D

Accession: 0002060755-25-000023 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0002074113
  • Entity Name:
    Vesalius Longevity Labs (Canada) Inc.
  • Entity Type:
    Corporation
  • Jurisdiction:
    BRITISH COLUMBIA, CANADA
  • Year of Inc:
    Within 5 years (2024)
  • Address:
    1500 - 1055 WEST GEORGIA STREET
    VANCOUVER, A1 V6E 4N7
  • Persons:
    Related Persons 9
    JOEL LEONOFF
    Director
    KEVIN RABBITT
    Executive Officer, Director
    MARK PATRICOF
    Director
    RICHARD SERBIN
    Director
    SHANNON ANDERSON
    Executive Officer, Director
    C. FRANK I. DUNSFORD
    Executive Officer
    JASON SUSLAK
    Executive Officer
    SHANNON LOUDEN
    Executive Officer
    TIMMOTHY EVE STUMP
    Executive Officer
EDGAR: Offering Information
  • Accession Date:
    06/30/2025
  • First Sale Date:
    05/23/2025
  • Offering Amount:
    $168,000
  • Amount Sold:
    $168,000
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity
  • Sales Clarification:
    Total Offering Amount represents the price of 8,400,000 common shares at $0.02 per share.
EFD: Current State Notices
View Notices

Notices found in EFD

Filed:CA, NM, NY, PR
EDGAR: Sales Compensation Recipient Information

There were no Sales Compensation Recipient Information associated with this Accession Number.

EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Vesalius Longevity Labs (Canada) Inc./s/ Kevin RabbittKevin RabbittCEO and Director2025-06-28